Thermosensitive Pluronic® F127-Based in situ gel formulation containing nanoparticles for the sustained delivery of paclitaxel

Thermosensitive Pluronic® F127-Based in situ gel formulation containing nanoparticles for the sustained delivery of paclitaxel

Bone metastasis is one of the most encountered complications among cancer patients and majority of cancer types has led to bone metastasis. Paclitaxel (PCX) is an anticancer agent commonly used in cancer treatment. However, its clinical use is restricted owing to poor water solubility. PCL NPs were...

Full description

Bibliographic Details
Main Authors: Sedat Unal, Merve Celik Tekeli, Osman Dogan, Yesim Aktas
Format: Article
Language:English
Published: Society of Turaz Bilim 2023-03-01
Series:Medicine Science
Subjects:
cancer
nanoparticles
paclitaxel
in situ gel
drug release
Online Access:https://www.medicinescience.org/?mno=132661

Similar Items

Similar Items